Clinical Trials Sponsored by Limited Liability Company Pharm Aid

Total 136 results

Limited Liability Company Pharm Aid

Completed

Reactogenicity, Safety and Immunological Efficacy of the Live, Pentavalent Rotavirus Vaccine in Childhood Immunization

Rotavirus Infection

Russian Federation
Limited Liability Company Pharm Aid

Completed

Safety and Immunological Efficacy of the Pentavalent Rotavirus Vaccine - Rota-V-Aid™ (Live Attenuated Oral, Freeze-dried) at Healthy Adults Aged 18 to 45 Years.

Rotavirus Infections | Rotavirus Vaccines

Russian Federation
VA Pharma Limited Liability Company

Unknown

Reactogenicity, Safety and Immunogenicity of an Universal Influenza Vaccine Uniflu

Safety Issues

Russian Federation
Limited Liability Company "Docstarclub"

Not yet recruiting

Digital Competencies of the Doctors

Emotional Intelligence | Doctor Patient Relation | Digital Competences | Emotional Burnout
Limited Liability Company "Docstarclub"

Completed

The Association of Cognitive Distortions and NCDs Among Users of Medical Internet Resources

Cognitive Biases | Non-infecious Chronic Disease

Russian Federation
Panagen, Limited Liability Company

Completed

Study of the Safety and Leukostimulatory Activity of the Preparation "Panagen" in Patients With Breast Cancer

Breast Cancer
Beijing Pearl Biotechnology Limited Liability Company

Completed

Study of a c-Met Inhibitor PLB1001 in Patients With PTPRZ1-MET Fusion Gene Positive Recurrent High-grade Gliomas

Glioma

China
Beijing Pearl Biotechnology Limited Liability Company

Completed

First-in-human Phase I Study of a Selective c-Met Inhibitor PLB1001

Non-Small Cell Lung Cancer

China
Beijing Pearl Biotechnology Limited Liability Company

Active, not recruiting

A Confirmatory Clinical Study in NSCLC Patients With MET Exon 14 Mutation (KUNPENG-2) (KUNPENG-2)

Non-small Cell Lung Cancer

China
Beijing Pearl Biotechnology Limited Liability Company

Unknown

Phase I Study of a Selective ALK Inhibitor PLB1003 in Patients With ALK+ NSCLC.

Non-Small Cell Lung Cancer

China
Beijing Pearl Biotechnology Limited Liability Company

Recruiting

A Study of PLB1001 in Non-small Cell Lung Cancer With c-Met Dysregulation(KUNPENG) (KUNPENG)

Non-small Cell Lung Cancer

China
Beijing Pearl Biotechnology Limited Liability Company

Active, not recruiting

A Study of PLB1001 Enteric Capsules in the Treatment of sGBM/IDH Mutant Glioblastoma Patients With the ZM Fusion Gene (FUGEN).

Glioblastoma

China
St. Louis University
Lucerno Dynamics Limited Liability Company (LLC)

Completed

Patterns and Prevalence of FDG Extravasation in PET/CT Scans (Lucerno device)

Intravenous Infiltration

United States
MAXVAX Biotechnology Limited Liability Company
Henan Center for Disease Control and Prevention

Active, not recruiting

Immunogenicity and Safety of Recombinant Herpes Zoster Vaccine (CHO Cells) in Healthy Subjects Aged 30 Years and Above

Herpes Zoster

China
MAXVAX Biotechnology Limited Liability Company
Henan Center for Disease Control and Prevention

Active, not recruiting

Safety and Immunogenicity of Recombinant Herpes Zoster Vaccine (CHO Cells) in Healthy Subjects Aged 18 Years and Above

Herpes Zoster

China
MAXVAX Biotechnology Limited Liability Company
Henan Center for Disease Control and Prevention

Active, not recruiting

Safety and Immunogenicity Study of Recombinant Trivalent Rotavirus Subunit Vaccine in Healthy Infants and Toddlers

Rotavirus Infections | Rotavirus Gastroenteritis

China
Ten Sun Pharma Company Limited

Completed

Efficacy and Safety of Esarin Gel in Chronic Venous Insufficiency and Varicose Veins

Chronic Venous Insufficiency | Varicose Vein | Superficial Vein Thrombophlebitis

Taiwan
Sun Pharma Advanced Research Company Limited

Active, not recruiting

Safety and Anti-leukemic Activity of Vodobatinib (K0706) for Treatment of Ph+ CML Resistant/Intolerant to ≥3 Prior CML Therapies

Healthy (For Part A) | Chronic Myeloid Leukemia (for Part B and C)

United States, Spain, Hungary, Italy, India, Belgium, France, Romania, Singapore, United Kingdom, Korea, Republic of, Turkey
Sun Pharma Advanced Research Company Limited

Completed

Evaluation of Safety and Efficacy of PDP-716

Ocular Hypertension | Open Angle Glaucoma

United States
Sun Pharma Advanced Research Company Limited

Completed

Evaluation of Efficacy and Safety of SDN-037

Inflammation and Pain Associated With Ocular Surgery

United States
Sun Pharma Advanced Research Company Limited

Completed

Safety and Tolerability Study of K0706 in Subjects With Parkinson's Disease

Parkinson Disease

United States
Sun Pharma Advanced Research Company Limited

Completed

To Evaluate the Safety, Tolerability and Pharmacokinetics of K0706 in Plasma and Cerebrospinal Fluid in Healthy Volunteers

Healthy

United States
Sun Pharma Advanced Research Company Limited

Completed

Bioavailability Study of SPARC001 (Study 2) in Healthy Adult Volunteers

Healthy

United States
Sun Pharma Advanced Research Company Limited

Completed

A Bioequivalence Study of SPARC_147709 in Patients With Multiple Myeloma

Multiple Myeloma
Sun Pharma Advanced Research Company Limited

Completed

Bioavailability Study of K0706 in Healthy Subjects

Healthy

United States
Sun Pharma Advanced Research Company Limited

Completed

Pharmacokinetic and Safety Study of SPARC1023 Alone and in Carboplatin Combination

Solid Tumor in Advanced Stage

United States
Sun Pharma Advanced Research Company Limited

Completed

Bioavailability Study of SPARC001 in Healthy Adult Volunteers

Healthy
Sun Pharma Advanced Research Company Limited

Completed

Efficacy and Safety of SPARC1310 in Seasonal Allergic Rhinitis

Seasonal Allergic Rhinitis

Canada
Sun Pharma Advanced Research Company Limited

Completed

To Evaluate the Relative Abuse Potential of Hydrocodone Bitartrate and Acetaminophen

Healthy

Canada
Sun Pharma Advanced Research Company Limited

Active, not recruiting

PROSEEK: A Phase 2 Study In Early Parkinson's Disease Patients Evaluating The Safety And Efficacy Of Abl Tyrosine Kinase Inhibition Using K0706

Early Parkinson Disease

United States, Spain, India, Hungary, Slovakia, Poland
Sun Pharma Advanced Research Company Limited

Completed

Study of Doxorubicin in Patients With Metastatic Breast Cancer/Advanced Ovarian Cancer

Breast Cancer and Ovarian Cancer
Sun Pharma Advanced Research Company Limited

Withdrawn

A Randomized, Open-Label, Comparative, Parallel-Group, Multicenter Study of SPARC1507

Advanced Biliary Tract Cancer

United States
Sun Pharma Advanced Research Company Limited

Completed

Bioequivalence Study of SPARC147609 in Patients With Ovarian Cancer

Ovarian Carcinoma

India
Sun Pharma Advanced Research Company Limited

Withdrawn

Evaluation of Efficacy and Safety of SPARC1401 in Acute Low Back Pain

Acute Muscle Pain
Sun Pharma Advanced Research Company Limited

Completed

Study of SPARC1103 in Subjects With Spasticity

Spasticity

United States, Russian Federation, Ukraine
Sun Pharma Advanced Research Company Limited

Completed

Pharmacokinetic Study of SPARC1613 and reference1613 in Subjects With Locally Recurrent or Metastatic Breast Cancer

Recurrent or Metastatic Breast Cancer

India
Sun Pharma Advanced Research Company Limited

Terminated

Bioavailability Study of SPARC1210 and Reference1210 in Subjects With Metastatic Breast Cancer

Breast Cancer

India
Sun Pharma Advanced Research Company Limited

Completed

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of SPARC1316

Asthma

United Kingdom
Sun Pharma Advanced Research Company Limited

Terminated

A Study in Patients With Advanced Breast Cancer

Advanced Breast Cancer | HER2-negative Breast Cancer | Hormone Receptor-positive Breast Cancer

United States, India
Sun Pharma Advanced Research Company Limited

Completed

Study to Determine Safety, Tolerability and Pharmacokinetics, of SCO-120 in Healthy Male and Post-menopausal Female Subjects

Healthy Volunteer Study

United States, Canada
Sun Pharma Advanced Research Company Limited

Completed

Evaluation of Safety of SPARC0913 in Open Angle Glaucoma or Ocular Hypertension

Ocular Hypertension | Open Angle Glaucoma

United States
Sun Pharma Advanced Research Company Limited

Completed

Efficacy and Safety of SPARC0912 and Reference0912 in Open Angle Glaucoma or Ocular Hypertension

Ocular Hypertension | Open Angle Glaucoma

United States
Sun Pharma Advanced Research Company Limited

Withdrawn

To Assess the Bioavailability and Safety of Paclitaxel Injection Concentrate for Suspension in Subjects With Locally Recurrent or Metastatic Breast Cancer

Metastatic Breast Cancer | Locally Recurrent Cancer

India
Sun Pharma Advanced Research Company Limited

Completed

Efficacy and Safety of SPARC0921 in Subjects With Spasticity

Spasticity

United States, Germany, Hungary, Russian Federation, Ukraine
Sun Pharma Advanced Research Company Limited

Completed

Safety and Efficacy of SPARC1203 in Allergic Rhinitis

Allergic Rhinitis

Germany
Sun Pharma Advanced Research Company Limited

Completed

Bioavailability Study of SPARC001(Study 1) in Healthy Adult Volunteers

Healthy

United States
Sun Pharma Advanced Research Company Limited

Completed

Safety Study of SPARC1104

Spasticity

United States
Sun Pharma Advanced Research Company Limited

Completed

Pharmacokinetic, Safety and Tolerability Study of SPARC1028

Solid Tumor in Advanced Stage

United States
Sun Pharma Advanced Research Company Limited

Completed

Effect of Different Concentrations of SPARC1102 on Allergic Conjunctivitis

Allergic Conjunctivitis

United States
Georgetown University
Sun Pharma Advanced Research Company Limited

Recruiting

K0706 for Patients Diagnosed With Dementia With Lewy Bodies

Dementia With Lewy Bodies

United States

Clinical Trials Sponsored by Limited Liability Company Pharm Aid

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Uzbekistan

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations